Image2_Amygdalin as a chemoprotective agent in co-treatment with cisplatin.PNG by Panayiota Christodoulou (13832038)

“…As attested by flow cytometry, combination treatment was associated with decreased the percentage of late apoptotic cells compared with monotherapy (fold-change of decrease = 1.6 and 4.5 for 15 and 20 μΜ, respectively). …”

Chemical Pressure-Driven Band Convergence and Discordant Atoms Intensify Phonon Scattering Leading to High Thermoelectric Performance in SnTe by Hongwei Ming (8708556)

“…These combined effects decrease Δ<i>E</i>_L‑Σ from 0.36 to 0.09 eV, leading to the enhanced <i>S</i> and average <i>PF</i>_avg. …”

Extraction time and mustard concentration for extraction of aquatic oligochaetes by using wet funnel by Satoshi Kaneda (571209)

“…In Exp. S1.2, a fresh volume of approximately 100 cc of stock soil which had been collected from the same station was used because the original stock soil sample had already been depleted at that point. …”

Table_3_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Propagation of GABA-induced hyperpolarization at the axon regulates AP generation. by Yang Xia (104600)

“…Right, group data showing a decrease in the mean frequency of APs after GABA iontophoresis at the axon trunk. **, P<0.01, paired t-test. …”

The effect of (+)-pentazocine and H₂O₂ on ONHAs viability. by Jing Zhao (21160)

“…At the highest concentration of PTZ (50μM), there was a trend toward decrease in viability that was not significant. …”

Table_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Table_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Image_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Image_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Table_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Table_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Table_3_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Image_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Image_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Prevalence, Incidence, and Sociodemographic Characterization of Uveitis in Colombia, 2015-2020 by Gabriela Florez-Esparza (17404252)

“…In 2020, there was a noticeable decrease in the incidence and prevalence of GU. …”

Efficacy of combined interventions including preventative NPIs (e.g., masking, distancing, lockdowns) and testing and isolation. by Emily Howerton (10988025)

“…Moves can maintain NPI intensity with a less sensitive test (thick arrows), decrease NPI intensity with the same test (medium arrows), and decrease NPI intensity with a less sensitive test (light arrows). …”

Piwi dissociates from mitotic nuage at the central spindle in a <i>klp10A</i>-dependent manner. by Zsolt G. Venkei (8575353)

“…Open arrowheads (D) point to a Piwi-positive nuage particle, sliding along and later releasing the MT bundle, without decreasing GFP-Piwi signal. …”

Data Sheet 2_Global, regional, and national burden of acute glomerulonephritis in children and adolescents: 1990–2021 analysis and future projections.docx by Ming Liu (105953)

“…In 2021, there were approximately 170,584 new cases, representing a decrease compared to earlier years, with an age-standardized incidence rate (ASIR) of 6.47 per 100,000 (95% UI: 4.79–8.45). …”

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B by Teerha Piratvisuth (279131)

“…<div><h3>Background and Aims</h3><p>The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. …”